中文产业新闻精选评分75Chinese source
强生FcRn阻断剂IMAAVY获FDA批准上市，用于温抗体型自身免疫性溶血性贫血
强生单抗获批上市，预测年销突破50亿美元
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
强生单抗获批上市，预测年销突破50亿美元
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.